Clinical trial
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2017
- Completion date
- September 30, 2018
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic steatosis, liver biopsy, mri, quantification